Advertisement

PharmacoEconomics & Outcomes News

, Volume 834, Issue 1, pp 19–19 | Cite as

Exenatide in T2DM in Spain: better outcomes, lower cost

Clinical study
  • 4 Downloads

Reference

  1. Capel M, et al. Cost-Effectiveness Analysis of Exenatide versus GLP-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus. PharmacoEconomics-Open : 23 Jul 2019. Available from: URL: https://doi.org/10.1007/s41669-019-0171-y

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations